Research Paper Volume 15, Issue 9 pp 3738—3758
Comprehensive analysis of the oncogenic and immunological role of FAP and identification of the ceRNA network in human cancers
Figure 4. Mutation feature of FAP in human cancers. (A) FAP alteration frequency in TCGA cancer cohorts. (B) Sites and case numbers of FAP mutations were presented. (C) Association between genetic alteration of FAP and clinical survival in ESCA, LIHC, and UCEC. Kaplan-Meier plots with log-rank p-value were shown.